1.
Amiri V, Mohammadi M, Farsani MRK, Gharehbaghian A, Hajifathali A, Khazaei Z, Farsani MA. Evaluation of UHRF1 and P16INK4A expression levels in newly diagnosed AML patients. BMRAT [Internet]. 27Sep.2018 [cited 23Dec.2024];5(9):2658-63. Available from: http://bmrat.biomedpress.org/index.php/BMRAT/article/view/475